Meet the Team

Renowned experts in biomedical research inspired by a strong entrepreneurial spirit with highly experienced management team
ISABEL PORTERO
JAVIER DOTOR
FRANCISCO TEJERA
GERARDO ENTRENA
ESTHER C. SANTAMARÍA
VERÓNICA SÁNCHEZ
MARIAN VILLARROEL
GUILLERMO ABIA
CARLOS GÓMEZ
ALBERTO VÁZQUEZ

Latests News and Events

Keep up to date with our latest news stories and events. Learn more about our innovative research, awards and grants.

Biohope has initiated the first Clinical Trial in hospitals

Biohope, in collaboration with the Transplantation Units of “Puerta de Hierro” and “La Paz” University Hospitals (Madrid), has recently launched a Clinical Trial to evaluate its products in real clinical conditions. This is the first clinical study included in the Clinical Plan Program of Biohope in Renal Transplantation, and it is fully funded by the…

BIOHOPE among the most relevant technology-based companies of the Community of Madrid

The Madri+d Foundation recently published the “NEBTS 4” guide, which includes a new edition of the most complete analysis of technological entrepreneurship in the Community of Madrid, through unpublished data on the determinants of entrepreneurship, internationalization and processes Strategies. Biohope is among the most important companies in the sector created between the 2nd quarter of 2012…

Biohope receives the Innovative-SME Seal from the General Secretariat of Science and Innovation, Ministry of Economy and Competitiveness

Biohope has been inscribed by the General Secretariat of Science and Innovation in the National Registry of Innovative Small-Medium Enterprises, ruled by the Ministry of Economy and Competitiveness. This award recognizes the efforts and contribution of SMEs in the development of new innovative solutions for priority objectives & markets in our Society. In order to…

Learn some more about our Research Plan

DIAGNOSTIC SOFTWARE

Software for the identification of patients at risk of rejection or patients who have developed tolerance to the transplanted organ, all who would benefit for treatment adjustment.

PERSONALIZED MEDICINE (IMMUNOBIOGRAM®)

Bioassay to support clinicians in the determination of the optimal combination/posology of immunosuppressant drugs.

We have a plan: achieved goals and next steps

Biohope is a fast-growing company that has achieved significant goals in less than one year of existence, and we keep on moving!

Patents

We have already patented the technology under our bioassay IMMUNOBIOGRAM, and we expect the project will deliver industrial property from our second product under development, a diagnosis software

Agreements with hospitals

We work with 9 top-class Transplant Units of 6 EU countries which participate in our clinical development plan at different stages

Health Administration support

We have been offered support to the project from 5 Public Administration entities, being the most revelant the Health Council of the Region of Madrid

Transplant Organizations

The National Transplant Organization of Spain, named ONT, support the project to scale up to European scope. ONT is the most renowed transplant organization in Europe and its model is used worldwide

R+D plan stepwise and ambitious

Biohope is to implement a pilot national study for prototypes optimization and then a big validation multicenter-European clinical trial will be performed

Fast to the clinic

Biohope products have been conceived to be ready to market in the short term, because the technology is simple to scale up industrially and easy to implement at the point of care

Do you want to join our team?

If you want to work in a collaborative environment where opportunities are offered, skills are stretched
and excellence is rewarded, you might be exactly what we’re looking for

SEND US YOUR MOTIVATIONS

“Things work out best for those who make the best of how things work out” – John Wooden

0
% Rejection in kidney transplants to 10 years
0
Cost of immunosuppression per year in kidney transplants
0
Transplantion patients in Spain during 2015
0
Organ Transplantions in Spain in 50 years.